Blood Clot Prevention

References

Aggoun Y, Szezepanski I, et al. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events in children. Pediatr Res. 2005 Aug;58(2):173-8.

Akiba S, Murata T, et al. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol Pharm Bull. 2000 Nov;23(11):1293-7.

Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension . 1995 Feb;25(2):155-61.

Ali M, Thomson M, et al. Antithrombotic activity of garlic: its inhibition of the synthesis of thromboxane-B2 during infusion of arachidonic acid and collagen in rabbits. Prostaglandins Leukot Essent Fatty Acids. 1990 Oct;41(2):95-9.

Ali M, Thomson M. Consumption of a garlic clove a day could be beneficial in preventing thrombosis. Prostaglandins Leukot Essent Fatty Acids. 1995 Sep;53(3):211-2.

Allman MA, Pena MM, et al. Supplementation with flaxseed oil versus sunflowerseed oil in healthy young men consuming a low fat diet: effects on platelet composition and function. Eur J Clin Nutr. 1995 Mar;49(3):169-78.

American Heart Association. Heart Disease and Stroke Statistics—2004 Update. Dallas , Tex : American Heart Association; 2004.

Anderson FA Jr, Wheeler HB, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991 May;151(5):933-8.

Anfossi G, Russo I, et al. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent. Thromb Res. 1999 Jun 1;94(5):307-16.

Anfossi G, Russo I, et al. N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. Eur J Clin Invest. 2001 May;31(5):452-61.

Arruzazabala ML, Valdes S, et al. Comparative study of policosanol, aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers. Pharmacol Res . 1997 Oct;36(4):293-7.

Batiste MC, Schaefer EJ. Diagnosis and management of lipoprotein abnormalities. Nutr Clin Care . 2002 May-Jun;5(3):115-23.

Beamer NB, Coull BM, et al. Persistent inflammatory response in stroke survivors. Neurology. 1998 Jun;50(6):1722-8.

Brinker A, He R, et al. Safety of ximelagatran. JAMA. 2005 Jun 15;293(23):2859; author reply 2859-60.

Carantoni M, Vigna GB, et al. Low levels of HDL cholesterol in hypothyroid patients with cardiovascular diseases. Minerva Endocrinol . 1997 Dec;22(4):91-7.

Carbajal D, Arruzazabala ML, et al. Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers. Prostaglandins Leukot Essent Fatty Acids . 1998 Jan;58(1):61-4.

Castano G, Mas R, et al. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. Int J Clin Pharmacol Res. 1999;19(4):105-16.

Chadarevian R, Bruckert E, et al. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab . 2001 Feb;86(2):732-7.

Chang CT , Fan MH, et al. Potent fibrinolytic enzyme from a mutant of Bacillus subtilis IMR-NK1. J Agric Food Chem. 2000 Aug;48(8):3210-6.

Chesney CM, Elam MB, et al. Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT). Am Heart J . 2000 Oct;140(4):631-6.

Collen A, Smorenburg SM, et al. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res. 2000 Nov 1;60(21):6196-200.

Corea F, Tambasco N, et al. Brain CT -scan in acute stroke patients: silent infarcts and relation to outcome. Clin Exp Hypertens . 2002 Oct-Nov;24(7-8):669-76.

Das I, Khan NS , et al. Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic applications. Curr Med Res Opin. 1995;13(5):257-63.

Diekman MJ, Anghelescu N, et al. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. J Clin Endocrinol Metab . 2000 May;85(5):1857-62.

Diekman MJ, van der Put NM, et al. Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol (Oxf) . 2001 Feb;54(2):197-204.

Dirsch VM, Kiemer AK , et al. Effect of allicin and ajoene, two compounds of garlic, on inducible nitric oxide synthase. Atherosclerosis. 1998 Aug;139(2):333-9.

Doggrell SA. CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction. Expert Opin Pharmacother. 2005 Aug;6(10):1761-4.

Durand P, Prost M, et al. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest . 2001 May;81(5):645-72.

Dutta-Roy AK , Crosbie L, et al. Effects of tomato extract on human platelet aggregation in vitro. Platelets . 2001 Jun;12(4):218-27.

Ebbesen LS Hyperhomocysteinemia, thrombosis and vascular biology. Cell Mol Biol (Noisy-le-grand). 2004 Dec;50(8):917-30.

El Sayed MS, Jones PG, et al. Exercise induces a change in plasma fibrinogen concentration: fact or fiction? Thromb Res. 1999 Dec 15;96(6):467-72.

Engelsen J, Nielson JD, et al. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment: a randomized, double-blind, placebo-controlled cross-over trial. Ugeskr Laeger. 2003 Apr 28;165(18):1868-71.

Fasey N, Brennan PJ, et al. Thrombosis prevention trial: follow-up study of practical implications. Br J Gen Pract. 2002 Mar;52(476):208-9.

Fiessinger JN, Huisman MV , et al. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA. 2005 Feb 9;293(6):681-9.

Green D, Hull RD , et al. Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet. 1992 Jun 13;339(8807):1476.

Hak AE, Pols HA, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med . 2000 Feb 15;132(4):270-8.

Heck AM, DeWitt BA, et al. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000 Jul 1;57(13):1221-7.

Hejna M, Raderer M, et al. Inhibition of metastases by anticoagulants. J Natl Cancer Inst . 1999 Jan 6;91(1):22-36.

Hull RD , Raskob GE, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med. 1992 Apr 9;326(15):975-82.

Hurlen M, Abdelnoor M, et al. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med. 2002 Sep 26;347(13):969-74.

Hussein WI , Green R, et al. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann Intern Med . 1999 Sep 7;131(5):348-51.

Imhof A, Koenig W. Exercise and thrombosis. Cardiol Clin. 2001 Aug;19(3):389-400.

Ikeda I, Yoshida H, et al. Effects of long-term feeding of marine oils with different positional distribution of eicosapentaenoic and docosahexaenoic acids on lipid metabolism, eicosanoid production, and platelet aggregation in hypercholesterolemic rats. Lipids. 1998 Sep;33(9):897-904.

Jarvik GP, Tsai NT , et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol . 2002 Aug 1;22(8):1329-33.

Johansson JO, Egberg N, et al. Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic men. J Cardiovasc Risk . 1997 Jun;4(3):165-71.

Kang WS, Chung KH, et al. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovasc Pharmacol . 2001 Dec;38(6):875-84.

Kang WS, Lim IH, et al. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb Res . 1999 Nov 1;96(3):229-37.

Keevil JG, Osman HE, et al. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr . 2000 Jan;130(1):53-6.

Kim-Park S, Ku DD. Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clin Exp Pharmacol Physiol. 2000 Oct;27(10):780-6.

Kim KM, Chun SB, et al. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic Biol Med. 2001 Apr 1;30(7):747-56.

Kim YS, Pyo MK, et al. Antiplatelet and antithrombotic effects of a combination of ticlopidine and Ginkgo biloba ext (EGb 761). Thromb Res. 1998 Jul 1;91(1):33-8.

Koenig W, Ernst E. Exercise and thrombosis. Coron Artery Dis. 2000 Mar;11(2):123-7.

Leary MC, Saver JL. Annual incidence of first silent stroke in the United States : a preliminary estimate. Cerebrovasc Dis . 2003;16(3):280-5.

Lee RT, Huang H. Mechanotransduction and arterial smooth muscle cells: new insight into hypertension and atherosclerosis. Ann Med . 2000 May;32(4):233-5.

Libby P. Atherosclerosis: the new view. Sci Am. 2002 May;286(5):46-55.

Lien EA, Nedrebo BG, et al. Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab . 2000 Mar;85(3):1049-53.

Lip GY, Chin BS, et al. Cancer and the prothrombotic state. Lancet Oncol. 2002 Jan;3(1):27-34.

Massy ZA, Keane WF. Pathogenesis of atherosclerosis. Semin Nephrol . 1996 Jan;16(1):12-20.

Mismetti P, Laporte S, et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001 Jul;88(7):913-30.

Muller B, Tsakiris DA, et al. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest . 2001 Feb;31(2):131-7.

Nedrebo BG, Hustad S, et al. Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smoking. J Intern Med . 2003 Nov;254(5):504-12.

Obertreis B, Giller K, et al. Anti-inflammatory effect of Urtica dioica folia extract in comparison to caffeic malic acid. Arzneimittelforschung. 1996 Jan;46(1):52-6.

Obertreis B, Ruttkowski T, et al. Ex-vivo in-vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-alpha and interleukin-1 beta secretion in human whole blood by extractum urticae dioicae foliorum. Arzneimittelforschung. 1996 Apr;46(4):389-94.

O'Brien CL, Gage BF. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation. JAMA. 2005 Feb 9;293(6):699-706.

Philipp CS, Cisar LA, et al. Effect of niacin supplementation on fibrinogen levels in patients with peripheral vascular disease. Am J Cardiol . 1998 Sep 1;82(5):697-9, A9.

Pignatelli P, Pulcinelli FM, et al. Vitamin E inhibits collagen-induced platelet activation by blunting hydrogen peroxide. Arterioscler Thromb Vasc Biol . 1999 Oct;19(10):2542-7.

Pignatelli P, Pulcinelli FM, et al. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr. 2000 Nov;72(5):1150-5.

Prandoni P, Lensing AW, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet. 1992 Feb 22;339(8791):441-5.

Prandoni P. Heparins and venous thromboembolism: current practice and future directions. Thromb Haemost. 2001 Jul;86(1):488-98.

Rahman K, Billington D. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J Nutr. 2000 Nov;130(11):2662-5.

Ridker PM, A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005 Mar 31;352(13):1293-304.

Sagesaka-Mitane Y, Miwa M, et al. Platelet aggregation inhibitors in hot water extract of green tea. Chem Pharm Bull ( Tokyo ). 1990 Mar;38(3):790-3.

Sciumbata T, Caretto P, et al. Treatment with modified heparins inhibits experimental metastasis formation and leads, in some animals, to long-term survival. Invasion Metastasis. 1996;16(3):132-43.

Shah BH, Nawaz Z, et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol. 1999 Oct 1;58(7):1167-72.

Siegel G, Walter A, et al. Pleiotropic effects of garlic. Wien Med Wochenschr . 1999;149(8-10):217-24.

Son DJ, Cho MR, et al. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. Prostaglandins Leukot Essent Fatty Acids. 2004 Jul;71(1):25-31.

Steiner M, Lin RS. Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J Cardiovasc Pharmacol. 1998 Jun;31(6):904-8.

Straub RH, Scholmerich J, et al. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases: substitutes of adrenal and sex hormones. Z Rheumatol. 2000;59(suppl 2):II/108-II/118.

Stroh S, Elmadfa I. In vitro studies of the effect of different mixture proportions of omega-3 and omega-6 fatty acids on thrombocyte aggregation and thromboxane synthesis in human thrombocytes. Z Ernahrungswiss. 1991 Sep;30(3):192-200.

Stusser R, Batista J, et al. Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients. Int J Clin Pharmacol Ther. 1998 Sep;36(9):469-73.

Teucher T, Obertreis B, et al. Cytokine secretion in whole blood of healthy subjects following oral administration of Urtica dioica L. plant extract. Arzneimittelforschung. 1996 Sep;46(9):906-10.

US Decennial for Life Tables for 1989-1991. Eliminating Certain Causes of Death, 1989-91. Vol 1, No. 4. Washington DC: US Public Health Service; September 1999. Publication PHS 99-1150-4.

Verissimo MT, Aragao A, et al. Physical excercise [sic] and thrombotic risk in the elderly. Rev Port Cardiol. 2001 Jun;20(6):625-39.

von Tempelhoff GF, Harenberg J, et al. Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized double-blind trial. Int J Oncol. 2000 Apr;16(4):815-24.